Moreover, in the realms of multiple myeloma and breast cancer, CD-138's significance is underscored by its binding to the survival factor APRIL, and it acts as a co-receptor for growth factors such as hepatocyte growth factor and epidermal growth factor, thereby promoting cell survival [47]. This evidence concerns the gene SDC1 and plasma cell myeloma.